Ori Spotlight
by Ori Biotech
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇬🇧GB · Life Sciences#1395K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.5K to 15K🎙 Weekly cadence·53 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 30K🇬🇧100% - Active Followers
Loyal subscribers who consistently listen
1.5K to 9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 11 epsHosts
Recent guests
Recent episodes
Hong-Ming Hu: Scaling TCR-T for solid tumors through ImmuXell's partnership with IRO®
Jul 2, 2026
45m 45s
Ken Harris: Why AI and automation are CGT’s next inflection point
Jan 27, 2026
1h 03m 25s
Joe DePinto: Why advanced therapies need a new delivery model
Jan 13, 2026
1h 04m 41s
Jonathan Gluck: A personal account of navigating myeloma and CAR-T therapy
Dec 16, 2025
55m 35s
John Khoury: The CGT developers who adapt new manufacturing techniques early will lead later
Dec 3, 2025
50m 11s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/2/26 | TCR-T cell therapysolid tumors+3 | Hong-Ming Hu | TCR-T cell therapyIRO® platform+2 | China | TCR-Tcell therapy+5 | — | 45m 45s | ||
| 1/27/26 | AIautomation+5 | Ken Harris | Omnia BioAmazon Web Services | — | AIautomation+8 | — | 1h 03m 25s | ||
| 1/13/26 | advanced therapiesdelivery model+4 | Joe DePinto | McKesson | — | advanced therapiesdelivery model+5 | — | 1h 04m 41s | ||
| 12/16/25 | myelomaCAR-T therapy+4 | Jonathan Gluck | Ori BiotechAn Exercise in Uncertainty | — | myelomaCAR-T therapy+5 | — | 55m 35s | ||
| 12/3/25 | advanced therapiesmanufacturing techniques+4 | John Khoury | Project Farma | — | CGTmanufacturing risk+3 | — | 50m 11s | ||
| 9/2/25 | CAR-T therapiesautoimmune disease+4 | Warner Biddle | Kyverna Therapeutics | — | CAR-Tautoimmune care+5 | — | 40m 41s | ||
| 8/12/25 | cell therapiesCGT trials+4 | Lavakumar Karyampudi | Moffitt Cancer Center | — | cell therapiesCGT+5 | — | 1h 00m 07s | ||
| 7/15/25 | cell therapymanufacturing strategy+4 | Henrik Andersen | Bristol Myers Squibb | — | cell therapiesautomation+4 | — | 54m 20s | ||
| 7/1/25 | biotechinvestor confidence+4 | Arsalan Arif | Endpoints NewsFinancial Times | — | biotechinvestor sentiment+4 | — | 47m 48s | ||
| 6/17/25 | automationregenerative medicine+4 | Dr. Julie Allickson | Mayo ClinicCenter for Regenerative Biotherapeutics | — | automationregenerative medicine+5 | — | 48m 37s | ||
| 6/3/25 | cell therapymanufacturing+3 | Aaron Vernon | Quell Therapeutics | — | cell therapymanufacturing systems+4 | — | 44m 07s |
Showing 11 of 11
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Ori Spotlight
Peaked at #139 in United Kingdom, currently #139 in United Kingdom.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| United Kingdom | — | #139 | #139 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.